Protara Therapeutics(TARA) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update ● On track to report preliminary data from six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in Q4 2024 ● Expect to dose first patient in pivotal trial for IV Choline Chloride in Q1 2025 ● Current cash resources are approximately $90 million, including net proceeds from April 2024 private placement, expected to fund operations into 2026 NEW YORK, August 6, 2024 – Protara Thera ...